We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Merck's Fosamax Patent Reinstated In E.U.

Law360 (March 29, 2007, 12:00 AM EDT) -- In a surprise victory for Merck & Co., the European Patent Office reinstated Wednesday the drug maker's critical patent for its osteoporosis drug Fosamax Once Weekly, nearly three years after it...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.